MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ocugen, Inc. - Common Stock (NQ:OCGN)

1.360 +0.060 (+4.62%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2
...
30 31 32 33 34 35 36 37 Next >
News headline image
Will This News Stop Ocugen Shares in Their Tracks? ↗
This high flyer is still up more than 260% this year. 
Via The Motley Fool
News headline image
Where Will Ocugen Be in 1 Year? ↗
This biotech underdog's dream of selling a coronavirus vaccine in the U.S. just went up in smoke. 
Via The Motley Fool
News headline image
OCUGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Ocugen, Inc. on Behalf of Ocugen Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Ocugen, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 11, 2021 ↗
Upgrades Barclays upgraded the previous rating for Ventas Inc (NYSE:VTR) from Equal-Weight to Overweight. In the first quarter, Ventas showed an EPS of $0.72, compared to... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Friday ↗
Barclays lowered Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) price target from $302 to $285. Vertex Pharmaceuticals shares fell 13.3% to $187.88 in pre-market trading.... 
Via Benzinga
News headline image
Why Ocugen Plummeted by Nearly 30% Today ↗
The company won't be getting emergency use authorization for Covaxin after all. 
Via The Motley Fool
News headline image
66 Biggest Movers From Yesterday ↗
Gainers Orphazyme A/S (NASDAQ: ORPH) shares jumped 302.3% to close at $21.00 on Thursday. Shares of the biopharmaceutical firm touched an intraday high of $77.77, running up 1,... 
Via Benzinga
News headline image
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ocugen, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
Mid-Afternoon Market Update: Nasdaq Rises 100 Points; Materialise Shares Slide ↗
Toward the end of trading Thursday, the Dow traded up 0.25% to 34,531.98 while the NASDAQ rose 0.72% to 14,011.75. The S&P also rose, gaining 0.51% to 4,241.13. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
EQUITY ALERT: Rosen Law Firm Encourages Ocugen, Inc. Investors with Losses to Inquire About Class Action Investigation – OCGN
From Rosen Law Firm
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Gainers NuCana (NASDAQ:NCNA) shares moved upwards by 16.17% to $3.16 during Thursday's regular session. NuCana's stock is trading at a volume of 4.7 million shares... 
Via Benzinga
News headline image
Mid-Day Market Update: Yiren Digital Rises Following Q1 Results; Ocugen Shares Slide ↗
Midway through trading Thursday, the Dow traded up 0.35% to 34,568.37 while the NASDAQ rose 0.5% to 13,981.31. The S&P also rose, gaining 0.46% to 4,238.79. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
42 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Orphazyme A/S (NASDAQ: ORPH) surged 105% to $10.71. Medley Management Inc. (NASDAQ: MDLY) shares jumped 78% to $10.39 after gaining 9% on Wednesday. Medley LLC recently... 
Via Benzinga
News headline image
Making Money in the Stock Market Is Easy -- If You Avoid This 1 Thing ↗
Get-rich-quick strategies rarely work. 
Via The Motley Fool
News headline image
Mid-Morning Market Update: Markets Open Higher; US Inflation Rate Increases to 5% ↗
Following the market opening Thursday, the Dow traded up 0.54% to 34,632.83 while the NASDAQ rose 0.72% to 14,011.98. The S&P also rose, gaining 0.58% to 4,243.96. The U.S.... 
Via Benzinga
Topics Stocks
News headline image
OCGN Stock: The COVAXIN News That Has Ocugen Plunging Today ↗
Retail investors refuse to let OCGN stock die, even as the company makes it known that it wouldn't be applying for a crucial authorization. 
Via InvestorPlace
News headline image
Why Ocugen Shares Are Getting Hammered Today ↗
Ocugen Inc (NASDAQ: OCGN) shares were trading 22.18% lower off the open Thursday at $7.24 after the company announced it will pursue a biologics license application path for... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers Verona Pharma (NASDAQ:VRNA) stock moved upwards by 15.2% to $7.5 during Thursday's pre-market session. The market value of their outstanding shares is at $434.... 
Via Benzinga
News headline image
Could Ocugen Be a Millionaire-Maker Stock? ↗
The ability of this biotech to sell its coronavirus vaccine in a timely manner has caused a lot of headaches for investors. 
Via The Motley Fool
News headline image
3 Tips for COVID Vaccine Stock Investing Right Now ↗
Coronavirus vaccine investing is far from over. 
Via The Motley Fool
Topics Cannabis
News headline image
60 Biggest Movers From Yesterday ↗
Gainers Ra Medical Systems, Inc. (NYSE: RMED) shares surged 87.3% to close at $9.14 on Monday on abnormally-high session volume. EXFO Inc. (NASDAQ: EXFO) gained 60.3% to settle... 
Via Benzinga
News headline image
Why Ocugen Stock Fell 31.1% in May ↗
The biopharmaceutical company, known for its portfolio of eye therapy drugs, has a COVID-19 vaccine in the works. 
Via The Motley Fool
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Gainers Nymox Pharmaceutical (NASDAQ:NYMX... 
Via Benzinga
News headline image
OCGN stock: The Big COVAXIN News Boosting Ocugen Today ↗
Today, OCGN stock is on the move as the company announced its intention to expand its commercialization rights to include Canada. 
Via InvestorPlace
News headline image
When It Comes to Ocugen Stock I’m Damned If I Do or Don’t ↗
After sprinting to $16.20 in early May, Ocugen’s fallen back to earth. What does it have to do to get OCGN stock back into double digits? 
Via InvestorPlace
News headline image
This New Vaccine Market Could Be Bigger for Ocugen Than the U.S. ↗
Ocugen is casting a wider net. 
Via The Motley Fool
News headline image
I Would Hope Inovio Isn’t Attracting ANY Serious Money ↗
It seems as though INO stock will have a tough time getting and staying in double digits 
Via InvestorPlace
News headline image
The Same Problems Persist for Ocugen in Marketing Covaxin ↗
OCGN stock is attempting an upward move on unrealistic expectations. There is no reason to believe it can move upward in the long term. 
Via InvestorPlace
News headline image
28 Stocks Moving in Thursday's Pre-Market Session ↗
Gainers GTT Communications, Inc. (NYSE: GTT) rose 41.6% to $3.54 in pre-market trading after jumping over 57% on Wednesday. Workhorse Group Inc. (NASDAQ: WKHS) rose 29.2% to $14... 
Via Benzinga
< Previous 1 2
...
30 31 32 33 34 35 36 37 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story